Amicus Therapeutics, Inc.
Symbol: FOLD
NASDAQ
10.4
USDDzisiejsza cena rynkowa
-20.1432
Wskaźnik P/E
-0.2119
Wskaźnik PEG
3.08B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Amicus Therapeutics, Inc. (FOLD) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1099.23 | 286.2 | 293.6 | 482.5 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 217.01 | 39.2 | 144.8 | 237.3 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 292.86 | 87.6 | 66.2 | 52.7 | ||||||||||||||||||||
balance-sheet.row.inventory | 195.02 | 59.7 | 23.8 | 26.8 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 191.73 | 49.5 | 40.2 | 34.8 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 1778.84 | 483.1 | 423.8 | 596.8 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 236.73 | 58 | 60.3 | 63.1 | ||||||||||||||||||||
balance-sheet.row.goodwill | 791.19 | 197.8 | 197.8 | 197.8 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 86.92 | 20.5 | 23 | 23 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 878.11 | 218.3 | 220.8 | 220.8 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 13.44 | 3.1 | 4.3 | -4.9 | ||||||||||||||||||||
balance-sheet.row.tax-assets | -10.36 | 0 | 4.9 | 4.9 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 75.82 | 15.5 | 10 | 24.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1193.74 | 294.8 | 300.4 | 308.3 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 2972.58 | 777.9 | 724.2 | 905.1 | ||||||||||||||||||||
balance-sheet.row.account-payables | 76.76 | 15.1 | 15.4 | 21.5 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 31.93 | 8.3 | 8.6 | 7.4 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 12.43 | 12.4 | 5.9 | 6.2 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1722.72 | 387.9 | 443.6 | 432.7 | ||||||||||||||||||||
Deferred Revenue Non Current | 17.72 | 0 | 4.7 | 7.3 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | -17.72 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 513.63 | 131.8 | 110.1 | 117.1 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1830.25 | 450 | 462.1 | 451.8 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 227.27 | 48.9 | 60.1 | 50.8 | ||||||||||||||||||||
balance-sheet.row.total-liab | 2465.01 | 617.7 | 601.1 | 597.8 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 6.77 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 11.48 | 2.9 | 2.8 | 2.8 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -10548.38 | -2684.1 | -2532.5 | -2295.9 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -4.04 | 5.3 | -12.1 | 5 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 11041.73 | 2836 | 2664.8 | 2595.5 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 507.56 | 160.2 | 123 | 307.4 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2972.58 | 777.9 | 724.2 | 905.1 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 507.56 | 160.2 | 123 | 307.4 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2972.58 | - | - | - | ||||||||||||||||||||
Total Investments | 220.09 | 42.3 | 144.8 | 237.3 | ||||||||||||||||||||
balance-sheet.row.total-debt | 1803.53 | 445.1 | 452.1 | 440.1 | ||||||||||||||||||||
balance-sheet.row.net-debt | 921.3 | 198.1 | 303.3 | 194.9 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -151.58 | -151.6 | -236.6 | -250.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 7.87 | 7.9 | 5.3 | 6.2 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -9.97 | -4.9 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 86.08 | 86.1 | 76.5 | 57.8 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -40.05 | -48 | -39.9 | -18.6 | |||||||||||||||||||
cash-flows.row.account-receivables | -20.11 | -20.1 | -17.3 | -8.2 | |||||||||||||||||||
cash-flows.row.inventory | -44.61 | -44.6 | -5.3 | -7.8 | |||||||||||||||||||
cash-flows.row.account-payables | 49.19 | 49.2 | -6.4 | 7.4 | |||||||||||||||||||
cash-flows.row.other-working-capital | -24.53 | -32.5 | -10.8 | -10 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 38.57 | 41.5 | 28 | 2.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -69.09 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -7.44 | -7.4 | -3.8 | -3.9 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -12.2 | 0 | 3.4 | 3.9 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -91.72 | -91.7 | -243.3 | -341.4 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 197.23 | 197.2 | 335.9 | 424 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 12.2 | 0 | 0 | -3.9 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 98.06 | 98.1 | 92.3 | 78.8 | |||||||||||||||||||
cash-flows.row.debt-repayment | -20.96 | -21 | -0.3 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 95.35 | 103.2 | 4.3 | 199.8 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -17.92 | 0 | -11.5 | -15 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -4.3 | -15 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 7.19 | -20.6 | 4.3 | 42.8 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 61.68 | 61.7 | -7.5 | 212.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 6.31 | 6.3 | -14.6 | -5 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 96.83 | 98.2 | -96.3 | 83.3 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 892.58 | 247 | 153.1 | 249.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 795.75 | 148.8 | 249.5 | 166.2 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -69.09 | -69.1 | -166.6 | -202.5 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -7.44 | -7.4 | -3.8 | -3.9 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -76.53 | -76.5 | -170.3 | -206.4 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 399.36 | 399.4 | 329.2 | 305.5 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 39.51 | 45.2 | 38.6 | 34.5 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 359.85 | 354.2 | 290.6 | 271 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 152.38 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | -8.69 | -15.9 | 5.3 | 6.2 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 431.11 | 427.7 | 495.1 | 471 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 470.62 | 472.9 | 533.7 | 505.4 | |||||||||||||||||||||
income-statement-row.row.interest-income | 7.08 | 7.1 | 3 | 0.5 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24.18 | 50.1 | 37.1 | 32.5 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -63.86 | -76.6 | -37.6 | -41.6 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -8.69 | -15.9 | 5.3 | 6.2 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -63.86 | -76.6 | -37.6 | -41.6 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24.18 | 50.1 | 37.1 | 32.5 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4.13 | 7.9 | 12.5 | 3.8 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | -94.93 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | -76.96 | -73.5 | -204.4 | -199.9 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | -150.1 | -150.1 | -242 | -241.6 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7.74 | 1.5 | -5.5 | 8.9 | |||||||||||||||||||||
income-statement-row.row.net-income | -151.58 | -151.6 | -236.6 | -250.5 |
Często zadawane pytania
Ile wynosi Amicus Therapeutics, Inc. (FOLD) aktywów ogółem?
Amicus Therapeutics, Inc. (FOLD) całkowite aktywa to 777880000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 218583000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.901.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -0.261.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -0.380.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -0.193.
Co to jest Amicus Therapeutics, Inc. (FOLD) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -151584000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 445059000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 427651000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 246994000.000.